Document:

stra_Ex10_1

		
			Exhibit 10.1
		

		
			 
		

		
			EMPLOYMENT AGREEMENT
		

		
			 
		

		
			THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of February 28, 2018 (the “Effective Date”), by and between STRAYER UNIVERSITY, LLC, a Maryland corporation (the “University”), and BRIAN W. JONES (the “Executive”).
		

		
			 
		

		
			WHEREAS, the Executive has been employed by the University and currently serves as its President; and
		

		
			 
		

		
			WHEREAS, the University desires to continue to employ the Executive from and after the Effective Date in the capacity of its President and the Executive desires to continue to be employed by the University in such capacity pursuant to the terms set forth herein; and
		

		
			 
		

		
			WHEREAS, the University and the Executive desire to enter into this Agreement in order to set forth the terms and conditions of the Executive’s continued employment with the University as President;
		

		
			 
		

		
			NOW, THEREFORE, in consideration of the premises and of the mutual covenants herein contained, it is agreed as follows:
		

		
			 
		

		
			1.             Employment.  The University hereby agrees to employ the Executive and the Executive hereby agrees to be employed by the University as its President upon the terms and conditions set forth herein.
		

		
			 
		

		
			2.             Term.  The Executive’s employment shall be for a term (the “Employment Term”) commencing on the Effective Date  and, subject to earlier termination under Section 8, expiring on the third anniversary thereof; provided, however, that commencing on the third anniversary of the Effective Date, and each anniversary thereafter, the Employment Term will automatically be extended for an additional year unless, not later than 4 months prior to the anniversary, the University or the Executive shall have given written notice to the other that it or the Executive, as the case may be, does not wish to have the Employment Term extended.
		

		
			 
		

		
			3.             Duties of the Executive.  The Executive shall serve as the University’s President, and as such shall have primary responsibility for the oversight, management and general operation of all of the operations of the University.  The Executive shall report to the University’s Board of Trustees (the “Board of Trustees”), and as an executive of the parent company Strayer Education, Inc. (the “Company”), to the Chief Executive Officer thereof, and shall be assigned those executive and academic policy and management duties that are consistent with the Executive’s position as President of the University.  The Executive shall devote substantially all of his working time and his best efforts, full attention and energies to the business of the University; provided, however, that it shall not be a violation of this Agreement for Executive to (a) devote reasonable periods of time to charitable and community activities  and engaging in industry or professional activities (including membership on the board of directors or governing body of other corporations or entities and participation on governmental panels and commissions), and/or (b) manage personal business interests and investments, in each case so long as such activities do not interfere with the performance of Executive’s responsibilities under this Agreement.
		

		
			 
		

		
			4.             Compensation.
		

		
			 
		

		
			(a)             Base Salary.  During the Employment Term, the University shall pay to the Executive a base salary of not less than $430,000.00 per annum (the “Base Salary”).  The Board of Trustees shall review Executive’s Base Salary annually (after approval of the forthcoming year’s budget and receipt of the prior year’s financial statements), and recommend to the Compensation Committee of the Board of Directors (the “Board”) of the Company increases as it may deem advisable.
		

		
			 
		

		
			(b)             Annual Non-Equity Incentive Compensation Target.  In addition to the Base Salary, the Executive shall be eligible to receive an annual non-equity incentive compensation award (the “Non-equity Incentive Compensation Award”) for each fiscal year of the University that ends during the Employment Term, under the non-equity incentive compensation plan in effect for senior executives of the Company (the “Plan”), based upon the achievement of objective performance goals.  The Executive’s target Non-equity Incentive Compensation Award under the Plan for 2018 shall be $215,000, and thereafter for each fiscal year during the Employment Term shall be
		

		
			
		

		
			

		 

 

		

		
			 
		

		
			such amount as shall be determined by the Board in accordance with the Plan, but shall be at least 50% of the Executive’s Base Salary for the year involved, provided that the University and the Company achieve the targeted level of performance under the Plan for the relevant fiscal year.  The targeted level of performance required to earn the targeted Non-equity Incentive Compensation Award amount shall be as agreed by the Board of Trustees (or the Executive Committee thereof) and the Compensation Committee of the Board of the Company, on the one hand, and the Executive, on the other hand.
		

		
			 
		

		
			(c)             Annual Restricted Share Grant Target.   Executive shall be entitled to a target share grant equivalent to $550,000 (“Restricted Shares”), awarded at the typical time that the Company makes such awards, with a four-year cliff vesting schedule and applicable performance criteria as may be established by the Compensation Committee of the Board of Directors.  All Restricted Shares shall vest in full on the earlier to occur of the vesting date contained in each award agreement, or the Term hereof (or such later date of extension of the Employment Term pursuant to Section 2 hereof), upon a Change in Control Resulting in Termination (as defined in any award agreement) or upon any other termination of the Executive’s employment without Cause under Section 8(a)(i) or 8(a)(ii), or upon Executive’s death or Disability under Section 8(c) of this Agreement.
		

		
			 
		

		
			5.             Executive Benefits.  In addition to the compensation described in Section 4, during the Employment Term, the University shall make available to the Executive, on the most favorable terms and conditions available to executive and management employees of the University or Company, (i) all Company sponsored employee benefit plans or arrangements and such other usual and customary benefits now or hereafter generally available to employees of the Company, and (ii) such benefits and perquisites as may be made available to senior executives of the Company as a group, including, without limitation, equity and non-equity incentive programs, director and officer insurance which includes coverage for service on other boards of directors at the request of the Company, governmental panels, etc., vacations, and retirement, deferred compensation and welfare plans.
		

		
			 
		

		
			6.             Expenses.  The University shall also pay or reimburse the Executive for reasonable and necessary expenses incurred by the Executive in connection with his duties on behalf of the University in accordance with the expense policy of the University applicable to members of senior management of the University.
		

		
			 
		

		
			7.             Place of Performance.  In connection with his employment by the University, unless otherwise agreed by the Executive, the Executive shall be based at the home campus of the University in Washington, D.C., except for travel reasonably required for University business and the University shall provide the Executive with appropriate office facilities, support staff and resources to perform his duties at such location.
		

		
			 
		

		
			8.             Termination.
		

		
			 
		

		
			(a)             Termination By the University without Cause.  The Executive’s employment hereunder and the Employment Term may be terminated by the University for any reason by written notice as provided in Section 16.  For purposes of this Agreement, the Executive will be treated as having been terminated by the University without Cause if the Executive terminates his employment with the University under the following circumstances: (i) the University breaches any material provision of this Agreement and fails to cure such breach within thirty (30) calendar days after receiving notice thereof from the Executive; (ii) there occurs a material reduction in the Executive’s authority, functions, duties or responsibilities as provided in Section 3 and the University fails to restore to the Executive such authority, functions, duties or responsibilities within thirty (30) calendar days after receiving notice thereof from the Executive; or (iii) the Executive’s employment is (A) terminated without cause within six (6) months of the effective date of a Change in Control (as defined in Section 10) or (B) there occurs a material reduction in the Executive’s authority, function, duties or responsibilities which causes the Executive’s resignation from the University within six (6) months of the effective date of a Change in Control of the University or Company (as defined in Section 10) (a “CIC Termination”).  In the event of such a termination without Cause pursuant to any of subsections 8(a)(i)-(iii) above or any other termination of the Executive’s employment by the University for any reason other than Cause (as defined in Section 9(d) herein), the Executive shall be entitled to the payments and benefits set forth in Section 9(a).
		

		
			 
		

		
			(b)             Termination By the University for Cause or Voluntary Termination By the Executive.   The Executive may voluntarily terminate his employment and this Agreement at any time by notice to the University as provided in Section 16.  In the event of a termination of the Executive’s employment by the
		

		
			
		

		
			

		 

 

		

		
			Executive during the Employment Term other than pursuant to Section 8(a) hereof or a termination by the University for Cause (as defined in Section 9(d) herein) during the Employment Term, the Executive shall be entitled to the payments and benefits set forth in Section 9(b).
		

		
			 
		

		
			(c)             Termination Due to Death or Disability.  In the event of a termination of the Executive’s employment during the Employment Term due to death or Disability (as defined herein), the Executive shall be entitled to the payments and benefits set forth in Section 9(c).
		

		
			 
		

		
			9.             Compensation and Benefits Upon Termination of Employment.
		

		
			 
		

		
			(a)             Termination by University Without Cause.  If the Executive’s employment hereunder is terminated by the University (including within the meaning of any of subsections 8(a)(i)-(iii) herein) for any reason other than for Cause (as defined in Section 9(d) herein) during the Employment Term, the University shall be obligated to pay to the Executive the following termination payments and make available the following benefits:
		

		
			 
		

		
			(i)             Accrued Rights.  The University shall, within ten (10) days of the date of termination, pay the Executive a lump-sum amount equal to the sum of (A) his earned but unpaid Base Salary through the date of termination, (B) any earned but unpaid Non-equity Incentive Compensation Award under Section 4(b) above, and (C) any business expenses due to the Executive from the University as of the date of termination.  In addition, the University shall provide to the Executive all payments, rights and benefits due as of the date of termination under the terms of the Company’s employee and fringe benefit plans and programs (other than severance plans or programs) in which the Executive participated during the Employment Term (together with such lump-sum payment, the “Accrued Rights”).
		

		
			 
		

		
			(ii)            Severance Payment.  The Company shall within thirty (30) days of the date of termination pay the Executive a lump sum payment in an amount equal to the amount of Base Salary, and annual target Non-equity Incentive Compensation Award prorated for the amount of time remaining in the Employment Term.
		

		
			 
		

		
			(iii)           Medical Benefits.  For the time remaining on the Employment Term subsequent to termination, or in the case of a declaration of a Disability until such time as the Disability has concluded, the University will arrange to provide the Executive with medical benefits substantially similar to those that the Executive was receiving or entitled to receive immediately prior to the date of termination, provided that if and to the extent that any benefit described in this paragraph is not or cannot be paid or provided under any policy, plan, program or arrangement of the University or any subsidiary, as the case may be, then the University will itself pay or provide for the payment to the Executive, his dependents and beneficiaries, of such benefits.
		

		
			 
		

		
			(iv)           Restricted Shares.  As of the date of the Executive’s termination hereunder for any reason, including under Section 8(a)(i) and 8(a)(ii) hereof, (other than a voluntary resignation or termination for Cause covered by Section 9(b) below), any unvested Restricted Shares then held by the Executive shall immediately and fully vest, unless explicitly provided otherwise in the agreement applicable to such restricted shares.  Notwithstanding any other provision in this Agreement, the Change in Control Resulting in Termination provisions of any restricted stock award agreement and not the Change in Control provision in Section 8(a)(iii) hereof shall control the vesting of shares.
		

		
			 
		

		
			(b)             Termination for Cause or Voluntary Termination By the Executive.  If the Executive’s employment hereunder is terminated during the Employment Term by the University for Cause (as defined in Section 9(d) hereof), or voluntarily terminated by the Executive other than pursuant to Section 8(a), (1) the University shall have no further obligations to the Executive hereunder, except to pay or provide to the Executive any and all Accrued Rights, and (2) all unvested Restricted Shares shall terminate immediately and be of no further force or effect.
		

		
			 
		

		
			
		

		
			

		 

 

		

		
			 
		

		
			(c)             Disability; Death.  If the Executive’s employment hereunder is terminated during the Employment Term by reason of the Executive’s Disability (as defined herein) or death, the University shall pay and provide the Executive (or his legal representative or estate) with the following:
		

		
			 
		

		
			(i)             Accrued Rights.  The University shall pay and provide to the Executive (or his legal representative or estate) any and all Accrued Rights, including all disability or life insurance benefits as applicable;
		

		
			 
		

		
			(ii)            Salary Continuation.  The University shall provide the Executive (or his legal representative or estate) with continued payment of the Executive’s then-current Base Salary for the period remaining in the Employment Term.
		

		
			 
		

		
			(iii)           Restricted Shares.  As of the date of the Executive’s termination under this paragraph, any unvested Restricted Shares shall immediately and fully vest.
		

		
			 
		

		
			(iv)             Medical Benefits.  In the event of the Executive’s Disability (as defined herein), until such time as the Disability has concluded the University will arrange to provide the Executive with medical benefits substantially similar to those that the Executive was receiving or entitled to receive immediately prior to the date of termination due to Disability, provided that if and to the extent that any benefit described in this paragraph is not or cannot be paid or provided under any policy, plan, program or arrangement of the University or any subsidiary, as the case may be, then the University will itself pay or provide for the payment to the Executive, his dependents and beneficiaries, of such benefits.
		

		
			 
		

		
			(d)             Termination for Cause.  For purposes of this Agreement, “Cause” shall mean:
		

		
			 
		

		
			(i)            the willful and continued failure by the Executive substantially to perform his duties hereunder (other than any such failure resulting from the Executive’s Disability or the University’s breach of this Agreement), which failure is not or cannot be cured within thirty (30) business days after the University has given written notice thereof to the Executive specifying in detail the particulars of the acts or omissions deemed to constitute such failure,
		

		
			 
		

		
			(ii)           the engaging by the Executive in willful misconduct which is materially injurious to the University, monetarily or otherwise,
		

		
			 
		

		
			(iii)          the Executive’s conviction of, or entry of a plea of nolo contendere with respect to, any felony, or
		

		
			 
		

		
			(iv)          the Executive’s breach of any material provision of this Agreement, if the Executive fails to cure such breach within thirty (30) business days after the University has given written notice thereof to the Executive.
		

		
			 
		

		
			For purposes of this definition, no act, or failure to act, on the Executive’s part shall be considered “willful” unless done, or omitted to be done, by the Executive in bad faith and without reasonable belief that the Executive’s action or omission was in the best interests of the University.  The Executive shall not be deemed to have been terminated for Cause unless and until the Board of Trustees of the University, and the Board of Directors of the Company, finds that the Executive’s termination for Cause is justified and has given the Executive written notice of termination, specifying in detail the particulars of the Executive’s conduct found by the Board to justify such termination for Cause.
		

		
			 
		

		
			(e)            Continued Service as President Emeritus.  At any point in the Employment Term the University and Company may determine, in their sole discretion, to appoint the Executive as President Emeritus which shall not be deemed a termination under Section 8 for any purposes, and the Executive shall be entitled to continue to receive his Base Salary and Annual Restricted Share Grant Target during his service as President Emeritus, as well as Medical Benefits.  All provisions of this Section 9 shall then be applicable to the Executive’s term of service as President Emeritus.
		

		
			
		

		
			

		 

 

		

		
			 
		

		
			(f)             Disability Defined.  “Disability” shall mean the Executive’s inability to perform the duties of his position with the University by reason of a medically determined physical or mental impairment which has existed for a continuous period of at least 26 weeks and which, in the written judgment of a physician, is likely to be of indefinite duration or to result in death.
		

		
			 
		

		
			(g)             No Obligation to Mitigate.  The Executive is under no obligation to mitigate damages or the amount of any payment provided for hereunder by seeking other employment or otherwise; provided, however, that the Executive’s coverage under the University’s medical benefit plans will terminate when the Executive becomes covered under any employee medical plan made available by another employer.  The Executive shall notify the University within thirty (30) days after the commencement of any such benefits.
		

		
			 
		

		
			10.           Change in Control.  As used herein, a “Change in Control” of the University or the Company shall mean the occurrence of any of the following:
		

		
			 
		

		
			(a)            The acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Ac ”)) (a “Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of more than 50% of either: (i) the then- outstanding shares of the Company’s Common Stock or (ii) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (“Voting Stock”); provided, however, that for purposes of this subsection (a), the following  shall not constitute a Change in Control:  any acquisition by any Person pursuant to a transaction which complies with clauses (i), (ii) and (iii) of subsection (c) of this Section 10; or
		

		
			 
		

		
			(b)            Individuals who constitute the Board of Directors of the Company as of the date hereof (the “Incumbent Board”) cease for any reason (other than death or disability) to constitute at least a majority of the Board; provided, however, that  any individual becoming a director subsequent to the date hereof whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without objection to such nomination) shall be considered as though such individual were a member of the Incumbent Board, but excluding for this purpose any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest (within the meaning of Rule 14a-11 of the Exchange Act) with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board or any of the Investors; or
		

		
			 
		

		
			(c)            Consummation of a reorganization, merger or consolidation or sale or other disposition of all or substantially all of the assets of the University or the Company with or to any Person  (a “Business Combination”), in each case, unless, following such Business Combination, (i) all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the Common Stock and Voting Stock of the Company immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of, respectively, the then-outstanding shares of common stock and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity which as a result of such transaction owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions relative to each other as their ownership, immediately prior to such Business Combination, of the Common Stock and Voting Stock of the Company, as the case may be, (ii) no Person (excluding any entity resulting from such Business Combination or any employee benefit plan (or related trust) sponsored or maintained by the Company or such entity resulting from such Business Combination) beneficially owns, directly or indirectly, more than 50% of, respectively, the then-outstanding shares of common stock of the entity resulting from such Business Combination, or the combined voting power of the then-outstanding voting securities of such corporation except to the extent that such ownership existed prior to the Business Combination and (iii) at least a majority of the members of the board of directors of the corporation resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board providing for such Business Combination;
		

		
			 
		

		
			
		

		
			

		 

 

		

		
			 
		

		
			(d)            Approval by the shareholders of the Company of a complete liquidation or dissolution of the Company; or
		

		
			 
		

		
			(e)           If the Company ceases to be the sole shareholder of the University.
		

		
			 
		

		
			11.           Confidentiality Agreement.
		

		
			 
		

		
			(a)            The Executive acknowledges that, in the course of his employment by the University, he will or may have access to and become informed of confidential or proprietary information which is a competitive asset of the University or Company (“Confidential Information”), including, without limitation, (i) the terms of any agreement between the University or Company and any employee, customer or supplier, (ii) pricing strategy, (iii) merchandising and marketing methods, (iv) product or course development ideas and strategies, (v) University and Company personnel training and development programs, (vi) financial results, (vii) strategic plans and demographic analyses, (viii) proprietary computer and systems software, and (ix) any non-public information concerning the University or Company, their employees, suppliers or customers.  The Executive agrees that he will keep all Confidential Information in strict confidence during his employment by the University and thereafter, and will never directly or indirectly make known, divulge, reveal, furnish, make available, or use any Confidential Information (except in the course of his regular authorized duties or as otherwise authorized on behalf of the University or Company).  The Executive agrees that the obligations of confidentiality hereunder shall be in effect at all times during the Employment Term and shall survive termination of his employment at the University for a period of six (6) years thereafter regardless of any actual or alleged breach by the University of this Agreement, unless and until any such Confidential Information shall have become, through no fault of the Executive, generally known to the public or the Executive is required by law to make disclosure (after giving the University and Company notice and an opportunity to contest such requirement).  The Executive’s obligations under this Section 11 are in addition to, and not in limitation of or preemption of, all other obligations of confidentiality which the Executive may have to the University and Company under general legal or equitable principles.
		

		
			 
		

		
			(b)            Except in the ordinary course of the University’s business, or as otherwise authorized on behalf of the University or Company, the Executive may not make or cause to be made, any copies, pictures, duplicates, facsimiles or other reproductions or recordings or any abstracts or summaries including or reflecting Confidential Information. All such documents and other property furnished to the Executive by the University or Company, or otherwise acquired or developed by the University or Company, shall at all times be the property of the University and Company.  Upon termination of the Executive’s employment with the University, the Executive will return to the University or destroy any such documents or other property of the University which are in the possession, custody or control of the Executive; provided that the Executive may maintain a copy in his possession (to be treated confidentially under this Section 11) of any information necessary for the Executive to enforce his legal rights under this Agreement or to file applicable tax returns.
		

		
			 
		

		
			(c)            Without the prior written consent of the University or Company, except in the ordinary course of the University’s or Company’s business, or to enforce his legal rights under this Agreement or support any tax filings referenced under subsection (b) above, or to comply with any legal disclosure requirement referenced in subsection (a) above, the Executive shall not at any time following the date of this Agreement use for the benefit or purposes of the Executive or for the benefit or purposes of any other person, firm, partnership, association, trust, venture, corporation or business organization, entity or enterprise or disclose in any manner to any person, firm, partnership, association, trust, venture, corporation or business organization, entity or enterprise any Confidential Information.
		

		
			 
		

		
			12.           Covenant Not to Compete.
		

		
			 
		

		
			(a)            For three (3) years after the date of termination of employment hereunder,  the Executive shall not, directly or indirectly, individually or on behalf of any other person or entity, (A) engage or  have an economic interest in (whether as owner, stockholder, partner, lender, consultant, employee, agent or otherwise) any business, activity or enterprise which is then directly and materially competitive with the business of any division or operation of the Company or the Company’s subsidiaries (collectively, the “Company Group”) in any region of the United States in which such business is then being conducted, it being understood that the Company Group currently is engaged primarily in the business of for-profit post-secondary education, or (B) hire or employ any person who has been an
		

		
			
		

		
			

		 

 

		

		
			 
		

		
			employee of any member of the Company Group at any time within 12 months prior to the Executive’s termination of employment or solicit, aid or induce such person to leave his or her employment with any member of the Company Group to accept employment with any other person or entity.  It is agreed that (i) not for profit educational entities that do not offer programs comparable to those of the Company  will not be deemed to be a direct competitor of the Company Group hereunder, (ii) foundations or other non-profit organizations furthering the interests of higher education will not be deemed a direct competitor of the Company Group hereunder; (iii) the Executive’s ownership of less than 1% of any class of stock in a publicly-traded corporation or his membership on any board of directors that is permissible under Section 3 hereof shall not be deemed a breach of this Section 12, and (iv) nothing herein shall be construed to prohibit general solicitation of employment by means of advertising.
		

		
			 
		

		
			(b)            The Executive acknowledges and agrees that a violation of Section 11 and the foregoing provisions of this Section 12 (referred to collectively as the Confidentiality and Noncompetition Agreement) would cause irreparable harm to the University and the Company, and that the University’s remedy at law for any such violation would be inadequate.  In recognition of the foregoing, the Executive agrees that, in addition to any other relief afforded by law or this Agreement, including damages sustained by a breach of this Agreement, and without the necessity or proof of actual damages, the University and the Company shall have the right to seek specific enforcement of  this Agreement, which may include, among other things, temporary and permanent injunctions, it being the understanding of the undersigned parties hereto that seeking damages and injunctions shall all be proper modes of relief and are not to be considered as alternative remedies.
		

		
			 
		

		
			13.           Agreement.  This Agreement supersedes any and all prior and/or contemporaneous agreements, either oral or in writing, between the parties hereto, with respect to the subject matter hereof.  Each party to this Agreement acknowledges that no representations, inducements, promises, or other agreements, orally or otherwise, have been made by any party, or anyone acting on behalf of any party, pertaining to the subject matter hereof, which are not embodied herein, and that no prior and/or contemporaneous agreement, statement or promise pertaining to the subject matter hereof that is not contained in this Agreement shall be valid or binding on either party.
		

		
			 
		

		
			14.           Withholding of Taxes.  The University may withhold from any amounts payable under this Agreement all federal, state, city or other taxes as the University is required to withhold pursuant to any law or government regulation or ruling.
		

		
			 
		

		
			15.           Successors and Binding Agreement.
		

		
			 
		

		
			(a)            The University will require any successor (whether direct or indirect, by purchase, merger, consolidation, reorganization or otherwise) to all or substantially all of the business or assets of the University, by agreement in form and substance satisfactory to the Executive, expressly to assume and agree to perform this Agreement in the same manner and to the same extent the University would be required to perform if no such succession had taken place.  This Agreement will be binding upon and inure to the benefit of the University and any successor to the University, including without limitation any persons acquiring directly or indirectly all or substantially all of the business or assets of the University whether by purchase, merger, consolidation, reorganization or otherwise (and such successor shall thereafter be deemed the “University” for the purposes of this Agreement), but will not otherwise be assignable, transferable or delegable by the University.
		

		
			 
		

		
			(b)            This Agreement will inure to the benefit of and be enforceable by the Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees and legatees.
		

		
			 
		

		
			(c)            This Agreement is personal in nature and neither of the parties hereto shall, without the consent of the other, assign, transfer or delegate this Agreement or any rights or obligations hereunder except as expressly provided in Sections 15(a) and 15(b).  Without limiting the generality or effect of the foregoing, the Executive’s right to receive payments and benefits hereunder will not be assignable, transferable or delegable by him, whether by pledge, creation of a security interest, or otherwise, other than by a transfer by the Executive’s will or by the laws of descent and distribution and, in the event of any attempted assignment or transfer contrary to this Section 15(c), the Company shall have no liability to pay any amount so attempted to be assigned, transferred or delegated.
		

		
			 
		

		
			16.           Notices.  For all purposes of this Agreement, all communications, including without limitation notices, consents, requests or approvals, required or permitted to be given hereunder will be in writing and will be
		

		
			
		

		
			

		 

 

		

		
			 
		

		
			deemed to have been duly given when hand delivered or dispatched by electronic facsimile transmission (with receipt thereof confirmed), or five (5) business days after having been mailed by United States registered or certified mail, return receipt requested, postage prepaid, or three business days after having been sent by a nationally recognized overnight courier service such as Federal Express, UPS, or similar courier service, addressed to the University (to the attention of the Secretary of the University) at its principal executive offices and to the Executive at his principal residence, or to such other address as either party may have furnished to the other in writing and in accordance herewith, except that notices of changes of address shall be effective only upon receipt.
		

		
			 
		

		
			17.           Governing Law.  The validity, interpretation, construction and performance of this Agreement will be governed by and construed in accordance with the substantive laws of the State of Maryland, without giving effect to the principles of conflict of laws of such State.
		

		
			 
		

		
			18.           Validity.  If any provision of this Agreement or the application of any provision hereof to any person or circumstances is held invalid, unenforceable or otherwise illegal, the remainder of this Agreement and the application of such provision to any other person or circumstances will not be affected, and the provision so held to be invalid, unenforceable or otherwise illegal will be reformed to the extent (and only to the extent) necessary to make it enforceable, valid or legal.
		

		
			 
		

		
			19.           Survival of Provisions.  Notwithstanding any other provision of this Agreement, the parties’ respective rights and obligations hereunder, will survive any termination or expiration of this Agreement or the termination of the Executive’s employment for any reason whatsoever.
		

		
			 
		

		
			20.           Miscellaneous.  No provision of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is in writing and signed by the party against whom such modification, waiver or discharge is sought to be enforced.  No waiver by either party hereto at any time of any breach by the other party hereto or compliance with any condition or provision of this Agreement to be performed by such other party will be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.  Unless otherwise noted, references to “Sections” are to sections of this Agreement.  The captions used in this Agreement are designed for convenient reference only and are not to be used for the purpose of interpreting any provision of this Agreement.
		

		
			 
		

		
			21.           Indemnification under Company By-Laws.  To the maximum extent provided in the bylaws of the University and/or Company and by law, during the term of this Agreement and thereafter, the University and Company  shall indemnify and hold the Executive and his heirs, personal representatives, executors and administrators harmless, against any and all claims, damages liabilities, costs of investigation and reasonable legal expenses as a result of any threatened or actual third-party claim or proceeding  (excluding claims and proceedings by the University and any of its affiliates)  against the Executive that arises by reason of the Executive having executed and performed under this Agreement (as it may be amended)  or otherwise having provided service as an officer or employee of the University, any affiliate of the Company or any other entity at the request of the Company.
		

		
			 
		

		
			22.           Section 409A.
		

		
			 
		

		
			(a)           It is intended that any amounts payable under this Agreement shall either be exempt from or comply with Section 409A of the Code and all regulations, guidance and other interpretive authority issued thereunder, including without limitation any such regulations or other guidance that may be issued in the future (“Section 409A”) so as not to subject the Executive to payment of any additional tax, penalty or interest imposed under Section 409A. The provisions of this Agreement shall be construed and interpreted to avoid imputation of any such additional tax, penalty or interest under Section 409A yet preserve the intended benefit payable to the Executive.
		

		
			 
		

		
			(b)           Notwithstanding anything herein to the contrary, if the Executive is a Specified Employee at the time of the Executive’s termination of employment with the University or Company and the deferral of the commencement of any payments or benefits otherwise payable hereunder as a result of such termination of employment is necessary to prevent any accelerated or additional tax under Section 409A, then the Company will defer the commencement of any such payments or benefits hereunder to the extent that such payments or benefits (after taking into account all exclusions applicable to such payment under Section 409A) constitute “deferred compensation” subject to Section 409A (without any reduction in such payments or benefits ultimately paid or
		

		
			
		

		
			

		 

 

		

		
			 
		

		
			provided to the Executive) until the earlier of (i) the first business day after the expiration of six (6) months following the Executive’s termination of employment (ii) or the Executive’s death or Disability (the “Delayed Payment Date”).
		

		
			 
		

		
			(c)           For purposes of this Agreement, any references herein to the Executive’s “termination of employment” or words of similar meaning shall refer to the Executive’s “separation from service” with the Company within the meaning of Section 409A and Treasury Regulation Section 1.409A-1(h) (after giving effect to the presumptions contained therein) and the term “Specified Employee” shall have the meaning given such term in Section 409A and Treasury Regulation Section 1.409A-1(i) as determined in accordance with the Company’s policy for determining Specified Employees.
		

		
			 
		

		
			(d)           (i) To the extent any reimbursements or in-kind benefits due to the Executive under this Agreement constitute “nonqualified deferred compensation” subject to Section 409A,  any such reimbursements or in-kind benefits shall be paid to the Executive in a manner consistent with Treasury Regulation Section 1.409A-3(i)(1)(iv), and (ii) to the extent that the Executive’s receipt of any in-kind benefits from the Company or its affiliates must be delayed pursuant to this Section 22 due to the Executive’s status as a Specified Employee, the Executive may elect to instead purchase and receive such benefits during the period in which the provision of benefits would otherwise be delayed by paying the Company (or its affiliates) for the fair market value of such benefits (as determined by the Company in good faith) during such period.  Any amounts paid by the Executive pursuant to the preceding sentence shall be reimbursed to the Executive as described above on the Delayed Payment Date.
		

		
			 
		

		
			(e)           Each payment made under this Agreement shall be treated as a separate payment and any right to a series of installment payments under this Agreement shall be treated as a right to a series of separate payments.
		

		
			 
		

		
			(f)           The University and the Company shall consult with the Executive in good faith regarding and shall use all reasonable efforts to agree with Executive on the appropriate implementation of the provisions of this Section 22.
		

		
			 
		

		
			IN WITNESS WHEREOF, with the Company signatory listed below having been duly authorized by the Company to enter into this Agreement by the Company, the parties hereto have executed this Agreement as of the day and year first written.
		

		
			 
		

			
					
						 

					
					
						STRAYER UNIVERSITY, LLC

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						By:

					
					
						/s/ Lizette Herraiz

				
	
					
						 

					
					
						 

					
					
						Name: Lizette Herraiz

				
	
					
						 

					
					
						 

					
					
						Title: General Counsel & Secretary

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						/s/ Brian W. Jones

				
	
					
						 

					
					
						 

					
					
						Brian W. JonesExhibit

Exhibit 10.1

AMENDMENT TO 
FIFTH AMENDED AND RESTATED FINANCING AND SECURITY AGREEMENT

THIS AMENDMENT TO FIFTH AMENDED AND RESTATED FINANCING AND SECURITY AGREEMENT (this “Amendment”) is made this 26th day of April, 2018, by GP Strategies Corporation, a Delaware corporation (“GP” or the “Borrower”), General Physics (UK) Ltd., GP Strategies Holdings Limited, GP Strategies Limited and GP Strategies Training Limited, each a company organized and existing under the laws of England and Wales (each individually, a “UK Borrower” and collectively, the “UK Borrowers”) and Wells Fargo Bank, National Association (the “Lender”).
RECITALS
A.The Borrower and the Lender are parties to a Fifth Amended and Restated Financing and Security Agreement dated as of December 15, 2016, as amended by this Amendment and as may be further amended, restated, supplemented or otherwise modified hereafter (the “Financing Agreement”), pursuant to which the Lender extended to (a) the Borrower certain credit facilities consisting of (i) a revolving credit facility in the maximum principal amount of US One Hundred Million Dollars ($100,000,000) (the “US Revolving Credit Facility”) with a letter of credit sub-facility in the maximum aggregate stated amount of US Fifteen Million Dollars ($15,000,000) (the “Letter of Credit Facility”) and (ii) a term loan in the original principal amount of US Forty Million Dollars ($40,000,000) (the “Term Loan”) and (b) the UK Borrowers a revolving credit facility in the maximum principal amount of US Ten Million Dollars ($10,000,000) to be advanced in Euros or Sterling subject to the Dollar cap.  All capitalized terms used, but not specifically defined herein, shall have the meanings given to such terms in the Financing Agreement.
B.     The Borrower has requested a revision of the financial covenant definitions contained in Section 6.1.13(a) of the Financing Agreement, and the Lender has agreed to the Borrower’s request, subject to the terms and conditions of this Amendment.
AGREEMENTS
NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, receipt of which is hereby acknowledged, the Borrower, the UK Borrowers and the Lender agree as follows:
1.The Recitals above are a part of this Amendment.  
2.    Each of the Borrower and the UK Borrowers represents and warrants to the Lender as follows:
(a)It is an entity duly organized, and validly existing and, with respect to the Borrower only, in good standing under the laws of the jurisdiction in which it was organized, has all requisite power and authority to carry on its business as now conducted and is qualified to do business in every jurisdiction where such qualification is required, except where the failure to do so in such jurisdiction would not have a material adverse effect on the ability of the Borrower and the UK Borrowers taken as a whole to perform the Obligations, on the conduct of the Borrower’s and the 

Exhibit 10.1

UK Borrowers’ operations taken as a whole, on the Borrower’s and the UK Borrowers’ financial condition taken as a whole, or on the value of, or the ability of Lender to realize upon, the Collateral.
(b)    It has the power and authority to execute and deliver this Amendment and perform its obligations hereunder and has taken all necessary and appropriate corporate action to authorize the execution, delivery and performance of this Amendment.
(c)    The Financing Agreement, as amended by this Amendment, and each of the other Financing Documents to which it is a party remains in full force and effect, and each constitutes its valid and legally binding obligation, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium and other laws affecting creditors' and secured parties’ rights and remedies generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law.
3.    The definition of the following term contained in Section 6.1.13(a) of the Financing Agreement is hereby deleted in its entirety and replaced by the following definition:
“Adjusted EBITDA” means, as to GP on a consolidated basis for any period of determination, EBITDA of GP and its consolidated Subsidiaries, minus dividends paid, plus, to the extent deducted in the determination of net income, non-cash compensation, plus unusual and non-recurring expenses related to significant ERP investment and restructuring costs, which for fiscal year 2017 shall not exceed $8,200,000 and for fiscal year 2018 shall not exceed $3,600,000.
4.    Effectiveness. Notwithstanding the date on which this Agreement is actually executed, it is agreed by the parties that the terms of this Amendment shall be retroactively effective as of March 31, 2018. 
5.    Notices.  All notices to GP under the Financing Agreement shall be sent to the attention of Michael Dugan, Executive Vice President and Chief Financial Officer.
6.    After giving effect to this Amendment, the Borrower and the UK Borrowers hereby ratify and confirm the representations, warranties and covenants contained in the Financing Agreement, except that to the extent any such representation, warranty or covenant by its express terms relates to an earlier date, such representation, warranty or covenant, as applicable, was true and correct in all material respects on and as of such earlier date.  The Borrower, the UK Borrowers and the Lender agree that this Amendment is not intended to and shall not cause a novation with respect to any or all of the Obligations.  Except as expressly modified herein, all of the terms, conditions and provisions of the Financing Agreement shall continue in full force and effect.
7.    The Borrower shall pay at the time this Amendment is executed and delivered by all of the parties hereto all fees, costs, charges and other expenses incurred by the Lender in connection with this Amendment, including, but not limited to, reasonable and properly documented fees and expenses of the counsel for the Lender.

Exhibit 10.1

8.    This Amendment is one of the Financing Documents.  This Amendment may be executed in any number of duplicate originals or counterparts, each of such duplicate originals or counterparts shall be deemed to be an original and all taken together shall constitute but one and the same agreement.  Each party to this Amendment agrees that the respective signatures of the parties may be delivered by fax, “.pdf,” or other electronic means acceptable to the Lender and that the parties may rely on a signature so delivered as an original.  Any party who chooses to deliver its signature in such manner agrees to provide promptly to the other parties a copy of this Amendment with its inked signature, but the party's failure to deliver a copy of this Amendment with its inked signature shall not affect the validity, enforceability and binding effect of this Amendment.
[Signatures Follow on Next Page]

Exhibit 10.1

Signature Page 1 of 2 to
Amendment to Fifth Amended and Restated Financing and Security Agreement 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their respective authorized officers as of the day and year first above written.

BORROWERS:

GP STRATEGIES CORPORATION

By:  /s/ Michael Dugan_________________
Name: Michael Dugan
Title: Executive Vice President and Chief Financial Officer

GENERAL PHYSICS (UK) LTD.

By:  /s/ Scott Greenberg_________________
Name: Scott Greenberg
Title:  Director

GP STRATEGIES HOLDINGS LIMITED

By:  /s/ Scott Greenberg__________________
Name: Scott Greenberg
Title:  Director

GP STRATEGIES LIMITED

By:  /s/ Scott Greenberg__________________
Name: Scott Greenberg
Title:  Director

GP STRATEGIES TRAINING LIMITED

By:  /s/ Scott Greenberg__________________
Name: Scott Greenberg
Title:  Director

Exhibit 10.1

Signature Page 2 of 2 to
Amendment to Fifth Amended and Restated Financing and Security Agreement

LENDER

WELLS FARGO BANK, NATIONAL ASSOCIATION

By:  /s/ Lynn Manthy___________________
Name: Lynn Manthy  
Title: Senior Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00282-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00282-of-00352.parquet"}]]